Piper Sandler Raises its Price Target on DexCom (DXCM)

On June 15, 2026, Piper Sandler expert Matt O'Brien raised the firm's terms people connected DexCom, Inc. (NASDAQ:DXCM) to $88 from $75 and maintained an Overweight standing connected the shares. O'Brien said Piper Sandler updated immoderate of its models to amended align with quarterly cadence, institution guidance, and statement estimates. For DexCom, the steadfast cited greater visibility into the semipermanent pipeline and catalyst cadence supporting sustained, outsized top-line growth.

On June 12, 2026, the U.S. Food and Drug Administration cleared DexCom, Inc.'s (NASDAQ:DXCM) Stelo Glucose Biosensor System for selling arsenic the archetypal over-the-counter continuous glucose show for children. The integrated CGM is indicated for radical 2 years of property and older who bash not usage insulin. The FDA had antecedently cleared Stelo OTC for individuals 18 years and older successful March 2024. Michelle Tarver, Director of the Center for Devices and Radiological Health, said the clearance reflects the FDA's committedness to supporting innovation for pediatric patients.

Pixabay/Public Domain

On June 10, 2026, TD Cowen expert Joshua Jennings raised the firm's terms people connected DexCom, Inc. (NASDAQ:DXCM) to $95 from $75 and maintained a Buy standing connected the shares. Jennings said DexCom appears to beryllium astatine the forefront of the T2NIT sum enlargement inaugural and that CONNECT represents a compelling dataset for payers. TD Cowen views DexCom arsenic a stock gainer successful the U.S. T2NIT market, portion noting that incremental entree should payment each players due to the fact that of the size of the opportunity.

DexCom, Inc. (NASDAQ:DXCM) designs, develops, and commercializes continuous glucose monitoring systems for diabetes and metabolic wellness absorption successful the United States and internationally.

While we admit the imaginable of DXCM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.